SPTX — SEAPORT THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 59 SEC-registered investment managers reported holding SPTX (SEAPORT THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $822.93M across 39.13M shares. Ownership is concentrated: the five largest holders account for 53.3% of reported value and the top ten for 74.8%.
Compared with the prior quarter, 59 opened new positions. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of SEAPORT THERAPEUTICS INC (SPTX) include ARCH Venture Management, LLC, GENERAL ATLANTIC, L.P., Sofinnova Investments, Inc., ranked by reported 13F value among the 77 institutional holders on this page.
SPTX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 40 | 14.23M | $284.55M | +9.8% |
| Q2 2026 | 59 | 39.13M | $822.93M | — |
Over the 2 quarters shown, institutional share counts decreased 64% in aggregate (Q2 2026 → Q3 2026).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 6.10M | $123.07M | 5.05% | Hold | |
| 1.84M | $37.07M | 0.00% | Add | |
| 1.60M | $29.84M | 0.00% | Reduce | |
| 1.10M | $22.09M | 0.53% | Hold | |
| 979.24K | $19.75M | 0.00% | Add | |
| 597.56K | $12.05M | 0.00% | Hold | |
| 377.39K | $7.61M | 0.00% | Reduce | |
| 377.23K | $7.61M | 0.00% | Add | |
| 298.54K | $6.02M | 0.01% | Reduce | |
| 250.80K | $5.06M | 0.00% | New | |
| 109.21K | $2.20M | 0.00% | Add | |
| 97.97K | $1.98M | 0.00% | Add | |
| 97.64K | $1.97M | 0.00% | Add | |
| 94.00K | $1.90M | 0.24% | New | |
| 70.92K | $1.43M | 0.01% | Add | |
| 65.94K | $1.23M | 0.00% | Add | |
| 29.49K | $594.79K | 0.00% | New | |
| 21.66K | $436.90K | 0.00% | New | |
| 18.60K | $375.22K | 0.00% | New | |
| 16.67K | $336.15K | 0.00% | Hold | |
| 14.11K | $284.54K | 0.00% | New | |
| 12.46K | $251.38K | 0.00% | Reduce | |
| 12.02K | $242.52K | 0.00% | New | |
| 11.68K | $235.52K | 0.00% | New | |
| 7.19K | $144.94K | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 6.29M | $136.60M | 12.41% | New | |
| 6.10M | $132.53M | 4.56% | New | |
| 3.56M | $77.43M | 4.12% | New | |
| 2.18M | $47.32M | 0.01% | New | |
| 2.06M | $44.77M | 19.27% | New | |
| 1.98M | $42.91M | 0.02% | New | |
| 1.82M | $40.89M | 0.01% | New | |
| 1.78M | $38.65M | 6.01% | New | |
| 1.31M | $28.42M | 0.00% | New | |
| 1.19M | $25.74M | 0.00% | New | |
| 1.10M | $23.89M | 0.50% | New | |
| 1.10M | $23.79M | 0.48% | New | |
| 1.08M | $23.45M | 0.01% | New | |
| 700.00K | $15.20M | 0.13% | New | |
| 599.22K | $13.01M | 0.00% | New | |
| 586.35K | $12.74M | 0.04% | New | |
| 500.00K | $10.86M | 0.43% | New | |
| 500.00K | $10.86M | 0.17% | New | |
| 414.67K | $9.01M | 0.00% | New | |
| 310.36K | $6.74M | 0.01% | New | |
| 279.18K | $6.06M | 0.00% | New | |
| 229.86K | $4.99M | 0.00% | New | |
| 225.00K | $4.89M | 0.20% | New | |
| 191.14K | $4.15M | 0.01% | New | |
| 175.87K | $3.82M | 0.00% | New |
New Positions (Q2 2026)
- ARCH Venture Management, LLC 6.29M sh · $136.60M
- GENERAL ATLANTIC, L.P. 6.10M sh · $132.53M
- Sofinnova Investments, Inc. 3.56M sh · $77.43M
- Goldman Sachs Group 2.18M sh · $47.32M
- TRV GP VI, LLC 2.06M sh · $44.77M
- CPP Investments 1.98M sh · $42.91M
- JPMorgan Chase & Co 1.82M sh · $40.89M
- Foresite Capital Management VI LLC 1.78M sh · $38.65M
- PRICE T ROWE ASSOCIATES INC /MD/ 1.31M sh · $28.42M
- Fidelity Management & Research (FMR) 1.19M sh · $25.74M
- Bellevue Group AG 1.10M sh · $23.89M
- Siren, L.L.C. 1.10M sh · $23.79M
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 |
|---|---|---|
| GENERAL ATLANTIC, L.P. | 6.10M | 6.10M |
| Fidelity Management & Research (FMR) | 1.84M | 1.19M |
| JPMorgan Chase & Co | 1.60M | 1.82M |
| Siren, L.L.C. | 1.10M | 1.10M |
| BlackRock Inc | 979.24K | 229.86K |
| VANGUARD CAPITAL MANAGEMENT LLC | 597.56K | 599.22K |
| Principal Global Investors | 377.39K | 414.67K |
| Geode Capital Management | 377.23K | 175.87K |
| Aberdeen Group plc | 298.54K | 310.36K |
| STATE STREET CORP | 250.80K | — |
| Manulife Financial | 109.21K | 82.56K |
| VANGUARD FIDUCIARY TRUST CO | 97.97K | 87.77K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 97.64K | 9.08K |
| AdvisorShares Investments LLC | 94.00K | — |
| ALPS ADVISORS INC | 70.92K | 54.33K |
| TD ASSET MANAGEMENT INC | 65.94K | 47.94K |
| BNY Mellon | 29.49K | — |
| Quadrature Capital Ltd | 21.66K | — |
| Nuveen, LLC | 18.60K | — |
| HighTower Advisors, LLC | 16.67K | 16.67K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold SPTX?
As of 2026-Q2, 59 institutional funds reported holding SPTX (SEAPORT THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $822.93M.
How many shares of SPTX do institutions own?
13F filers reported 39.13M shares of SPTX, worth $822.93M in aggregate at the end of 2026-Q2.
Is institutional ownership of SPTX rising or falling?
No prior-quarter baseline is available for a directional read.
Who are the top institutional holders of SPTX?
The largest 13F holders are ARCH Venture Management, LLC, GENERAL ATLANTIC, L.P., Sofinnova Investments, Inc., Goldman Sachs Group, TRV GP VI, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of SEAPORT THERAPEUTICS INC?
The major shareholders of SEAPORT THERAPEUTICS INC (SPTX) by reported 13F value are ARCH Venture Management, LLC, GENERAL ATLANTIC, L.P., Sofinnova Investments, Inc., Goldman Sachs Group, TRV GP VI, LLC, among 77 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.